During the past decade, McCreery Cancer Center at Ottumwa Regional conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 45 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McCreery Cancer Center at Ottumwa Regional" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 43 trials, followed by "Eastern Cooperative Oncology Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NSABP Foundation Inc" with 6 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McCreery Cancer Center at Ottumwa Regional" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "McCreery Cancer Center at Ottumwa Regional" are "Breast Cancer" (23 trials), "Lung Cancer" (11 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (9 trials), "Melanoma (Skin)" (7 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "McCreery Cancer Center at Ottumwa Regional" in a lesser frequency.

Most popular intervention types in "McCreery Cancer Center at Ottumwa Regional" are "Drug" (58 trials), "Other" (26 trials), "Biological" (23 trials), "Dietary Supplement" (7 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (21 trials), "bevacizumab" (11 trials), "carboplatin" (6 trials), "gemcitabine hydrochloride" (5 trials) and "radiation therapy" (5 trials). Other intervention names were less common.

The vast majority of trials in "McCreery Cancer Center at Ottumwa Regional" are 54 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "McCreery Cancer Center at Ottumwa Regional". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in McCreery Cancer Center at Ottumwa Regional, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in McCreery Cancer Center at Ottumwa Regional, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".